With the majority of normal adult CXCR4+ cells being quiescent, a tubulin polymerization inhibitor as payload enhances selective killing of highly proliferative tumour cells, thereby reducing normal tissue toxicity and improving TI. Here, CXCR4 is linked to neoplasm.